Rexahn Pharmaceuticals to Present at Two Upcoming Conferences
13 Mar 2018 //
PRESS RELEASE
Rexahn Collab with Zhejiang Haichang Biotech for the Dev of RX-0201 Archexin®
08 Feb 2018 //
PRESS RELEASE
Rexahn Receives Notice of Allowance for A New U.S. Patent-RX-5902 (Supinoxin™)
29 Jan 2018 //
PRESS RELEASE
Rexahn New Preclinical Data on Supinoxin™ at 2017 S.A Breast Cancer Symposium
11 Dec 2017 //
PRESS RELEASE
Rexahn Announces $8 Million Registered Direct Offering
13 Oct 2017 //
PRESS RELEASE
Rexahn Pharmaceuticals Receives New U.S. Patent for Supinoxin™
13 Aug 2017 //
PRESS RELEASE